tirzepatide discontinuation weight regain November Blog Alternative dosing regimens of GLP-1

Learn about the usage, dosage, side-effects of carnitine

The JAMA 2026 Research: What Actually Happens at the Pharmacy Counter A cross-sectional study published in JAMA Health Forum on April 17, 2026, using 2024 IQVIA retail pharmacy claims data, measured what happens after a branded medication faces an initial prior authorization rejection at the pharmacy

Key takeaways Ozempic (semaglutide) and Trulicity (dulaglutide) are FDA-approved GLP-1 receptor agonists used for Type 2 diabetes and cardiovascular risk reduction

Supporting Weight Loss: Due to their appetite-suppressing effects, GLP-1 medications have been shown to support weight loss in individuals with type 2 diabetes and obesity

No phase III clinical trial in humans has been published to date in indexed journals

Such data suggests that GLP1R may be able to stimulate the proliferation of existing beta cells